Ligand Pharmaceuticals Incorporated (LGND) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Ligand Pharmaceuticals Incorporated  (NASDAQ: LGND)
 

Ligand Pharmaceuticals Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ligand Pharmaceuticals Incorporated inventory turnover ratio, the Ligand Pharmaceuticals Incorporated's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.91 in the second quarter 2026, yet the ratio remained below the average, as LGND's market remain challenging.Average inventory processing period, for the Ligand Pharmaceuticals Incorporated in Jun 30 2026 quarter, has decreased to 125 days, compare to 139 days, in the Mar 31 2026 quarter.

Within Healthcare sector 135 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 904 in the first quarter 2026, to 1334.

LGND Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ligand Pharmaceuticals Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LGND Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -33.74 % -9.22 % -35.34 % -28.91 % -17.05 %
Y / Y Cost of Sales Growth -1.95 % -1.94 % -1.96 % -1.95 % 0.01 %
Inventory Turnover Ratio (TTM) 2.91 2.62 2.56 2.34 2.17
LGND's Total Ranking # 1334 # 904 # 953 # 900 # 1263
Average inventory processing period 126 140 143 156 168
Seq. Inventory Growth -22.64 % 45.36 % -23.31 % -23.17 % 5.99 %
Seq. Cost of Sales Growth 0 % 0.01 % -0.01 % -1.95 % 0.01 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 136
Overall Market # 1334

Inventory Turnover Ratio Statistics
High Average Low
8.9 2.91 1.33
(Dec 31 2014)   (Sep 30 2023)



LGND Company Profile >> Back to LGND Efficiency Comparisons >> Compare LGND Inventory Turnover Ratio to its Competitors

Financial Statements
Ligand Pharmaceuticals Incorporated's Inventories $ 10 Millions Visit LGND's Balance sheet
Ligand Pharmaceuticals Incorporated's Cost of Revenues TTM $ 32 Millions Visit LGND's Income Statement
What are LGND's Sales? Visit LGND's Sales by Segment

Other Inventory Turnover Ratios
Ligand Pharmaceuticals Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LGND's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LGND's Competitors
Inventory Turnover Ratio for LGND's Suppliers
Inventory Turnover Ratio for LGND's Customers

You may also want to know
LGND's Sales Growth Rates LGND's Pe Price to earnings ratio LGND's Receivables Turnover Ratio LGND's Stock Quote
LGND's Net Income Growth Rates LGND's Ps Price to Sales ratio LGND's Sales per Employee LGND's Asset Turnover Ratio
LGND's Net Margin LGND's Pb Price to Book ratio LGND's Financial Strength Ratios LGND's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions

Date modified: 2026-08-14T20:33:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.